Washington: Researchers have revealed that taking aspirin during an IVF cycle does not raise a woman``s chances of falling pregnant.
Their systematic review did not find compelling evidence to support the routine use of aspirin in women being treated for IVF.
The use of aspirin during IVF treatment is controversial. Part of the thinking behind any potential benefit is that aspirin may improve the blood flow to the womb and ovaries.
However, there are also concerns that taking aspirin may cause miscarriage or complications in pregnancy.
The latest study analysed women who were undergoing IVF and in most cases, aspirin was taken as a 100 mg dose once a day.
The result concluded that there was no evidence that aspirin would improve a woman’s chances of conceiving compared to placebo.
Large trials showing beneficial effects would now be needed to change these conclusions, according to the researchers.
“Couples undergoing IVF often feel so desperate that they are prepared to try anything that may improve their chances of conceiving,” said lead researcher Charalambos Siristatidis of the Assisted Reproduction Unit at the University of Athens in Greece.
“But given the current evidence, there is still no basis to recommend that women take aspirin to help them become pregnant,” he added.
The study was published in The Cochrane Library.